Skip to content
2000
Volume 16, Issue 2
  • ISSN: 1574-8936
  • E-ISSN: 2212-392X

Abstract

Background: The advancement of bioinformatics and machine learning has facilitated the diagnosis of cancer and the discovery of omics-based biomarkers. Objective: Our study employed a novel data-driven approach to classifying the normal samples and different types of gastrointestinal cancer samples, to find potential biomarkers for effective diagnosis and prognosis assessment of gastrointestinal cancer patients. Methods: Different feature selection methods were used, and the diagnostic performance of the proposed biosignatures was benchmarked using support vector machine (SVM) and random forest (RF) models. Results: All models showed satisfactory performance in which Multilabel-RF appeared to be the best. The accuracy of the Multilabel-RF based model was 83.12%, with precision, recall, F1, and Hamming- Loss of 79.70%, 68.31%, 0.7357 and 0.1688, respectively. Moreover, proposed biomarker signatures were highly associated with multifaceted hallmarks in cancer. Functional enrichment analysis and impact of the biomarker candidates in the prognosis of the patients were also examined. Conclusion: We successfully introduced a solid workflow based on multi-label learning with High- Throughput Omics for diagnosis of cancer and identification of novel biomarkers. Novel transcriptome biosignatures that may improve the diagnostic accuracy in gastrointestinal cancer are introduced for further validations in various clinical settings.

Loading

Article metrics loading...

/content/journals/cbio/10.2174/1574893615999200623130416
2021-02-01
2025-06-12
Loading full text...

Full text loading...

/content/journals/cbio/10.2174/1574893615999200623130416
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test